Longitude Capital Partners IV, LLC - 11 Sep 2025 SCHEDULE 13D Report for CG Oncology, Inc. Common Stock, $0.0001 par value per share (CGON)

Filing Manager
Longitude Capital Partners IV, LLC
Reporting Manager
Patrick G. Enright
Security
CG Oncology, Inc. Common Stock, $0.0001 par value per share
Symbol
CGON
Shares outstanding
77,704,467 shares
Disclosed Ownership
4,662,268 shares
Ownership
6%
Form type
SCHEDULE 13D
Filing time
18 Sep 2025, 20:37:24 UTC
Date of event
11 Sep 2025
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Longitude Capital Partners IV, LLC 4.1% 3,190,463 0 3,190,463 /s/ Cristiana Blauth Oliveira Cristiana Blauth Oliveira, Authorized Signatory 0001829169
Longitude Venture Partners IV, L.P. 4.1% 3,190,463 0 3,190,463 /s/ Cristiana Blauth Oliveira Cristiana Blauth Oliveira, Authorized Signatory 0001787456
Longitude Prime Partners, LLC 1.9% 1,471,805 0 1,471,805 /s/ Cristiana Blauth Oliveira Cristiana Blauth Oliveira, Authorized Signatory 0001865779
Longitude Prime Fund, L.P. 1.9% 1,471,805 0 1,471,805 /s/ Cristiana Blauth Oliveira Cristiana Blauth Oliveira, Authorized Signatory 0001865844
Patrick G. Enright 6% 4,662,268 0 4,662,268 /s/ Cristiana Blauth Oliveira Cristiana Blauth Oliveira as attorney-in-fact for Patrick G. Enright 0001253886
Juliet Tammenoms Bakker 6% 4,662,268 0 4,662,268 /s/ Cristiana Blauth Oliveira Cristiana Blauth Oliveira as attorney-in-fact for Juliet Tammenoms Bakker 0001431159